Longevity remains the largest untapped investment opportunity in a lifetime. The science of ageing, extending life and prevention is driven by advancements in synthetic biology and biotech that have been advancing 500% faster than Moore's Law for two decades.
Longevity impacts everything as more than 1billion people are at the age of retirement, remain largely unserved by healthcare, financial products, insurance and investment.
Copyright © 2022 SXV is a trading name for Solarix Ventures Ltd - All Rights Reserved.
Powered by GoDaddy